Loading
Latest filing published 08 Oct 2020 for CannaPharmaRx, Inc..
No signal scores available.
Andrew Steedman discloses dealings in CannaPharmaRx, Inc. to SEDI. The record holds 2 filings, for trades running from 23 April 2019 to 11 August 2020.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 8 October 2020 came the latest disclosure, a transaction in CannaPharmaRx, Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations